You have 9 free searches left this month | for more free features.

Alzheimer Disease (MMSE 15-23 and CDR1 or 2)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer, Alzheimer 1, Alzheimer 2 Trial in United States (Sensory Stimulation System (GS120) - Active, Sensory Stimulation

Recruiting
  • Alzheimer Disease
  • +34 more
  • Sensory Stimulation System (GS120) - Active
  • Sensory Stimulation System (GS120) - Sham
  • Washington, District of Columbia
  • +24 more
Jan 27, 2023

Alzheimer's Disease, Dementia Trial in Toronto, Riga (drug, genetic, other, behavioral)

Active, not recruiting
  • Alzheimer's Disease
  • Dementia
  • Spinal anesthesia group: bupivacaine 10-15mg
  • +4 more
  • Toronto, Ontario, Canada
  • +2 more
May 31, 2021

Alzheimer, Alzheimer 1, Alzheimer 2 Trial in Ventura (No Intervention)

Recruiting
  • Alzheimer Disease
  • +22 more
  • No Intervention
  • Ventura, California
    ProgenaBiome
Sep 2, 2021

People Who Have Genetic Changes and Features of Autism: Simons

Recruiting
  • 16P11.2 Deletion Syndrome
  • +184 more
    • New York, New York
    • +1 more
    Jan 6, 2023

    Mild Cognitive Impairment, Mild Dementia, Fasting-Mimicking Diet Trial in Genoa, Genova, Perugia (Fasting-Mimicking Diet

    Recruiting
    • Mild Cognitive Impairment
    • +2 more
    • Fasting-Mimicking Diet ProlonADTM
    • Genoa, GE, Italy
    • +2 more
    Jul 27, 2022

    Alzheimer Trial in Worldwide (AL002, Placebo)

    Recruiting
    • Alzheimer Disease
    • Phoenix, Arizona
    • +93 more
    Jul 21, 2022

    Alzheimer's Disease Trial in Worldwide (Placebo, Gantenerumab)

    Completed
    • Alzheimer's Disease
    • Sun City, Arizona
    • +130 more
    May 23, 2022

    Alzheimer Trial in Worldwide (LY3372689, Placebo)

    Active, not recruiting
    • Alzheimer Disease
    • Canoga Park, California
    • +70 more
    Jan 18, 2023

    Alzheimer's Disease Trial in Worldwide (Gantenerumab, Placebo)

    Completed
    • Alzheimer's Disease
    • Phoenix, Arizona
    • +138 more
    Dec 10, 2021

    Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)

    Active, not recruiting
    • Alzheimer's Disease
    • Garden Grove, California
    • +48 more
    Sep 1, 2022

    Alzheimer's Disease, Dementia, Brain Diseases Trial in Daejeon, Busan, Seoul (ATNC MDD-V1 (Real TMS + Real Cog), ATNC MDD-V1

    Recruiting
    • Alzheimer's Disease
    • +7 more
    • ATNC MDD-V1 (Real TMS + Real Cog)
    • ATNC MDD-V1 (Sham TMS + Real Cog)
    • Daejeon, Jung-gu, Korea, Republic of
    • +2 more
    Oct 11, 2023

    Cognitive Disorders Trial (Blood samples, Interviewing the subject and scales, Neurocognitive evaluation)

    Not yet recruiting
    • Cognitive Disorders
    • Blood samples
    • +5 more
    • (no location specified)
    May 25, 2023

    Alzheimer 3, Epilepsy Trial in Changsha (Lacosamide 100 mg, Levetiracetam 250mg)

    Recruiting
    • Alzheimer Disease 3
    • Epilepsy
    • Lacosamide 100 mg
    • Levetiracetam 250mg
    • Changsha, Hunan, China
      Xiangya Hospital of Central South University
    Aug 2, 2023

    Alzheimer Trial in Ramat Gan (SCI -110)

    Recruiting
    • Alzheimer Disease
    • SCI -110
    • Ramat Gan, Israel
      The Israeli Medical Center for Alzheimer's
    Feb 3, 2022

    Cognitive Health in Ageing Register: Investigational,

    Active, not recruiting
    • Alzheimer's Disease
    • Plaque, Amyloid
      • Edinburgh, United Kingdom
      • +1 more
      Jan 31, 2023

      Alzheimer (AD) Trial in Canada, Japan, United States (LY3303560, Placebo)

      Completed
      • Alzheimer Disease (AD)
      • Phoenix, Arizona
      • +59 more
      Aug 12, 2022

      Alzheimer Trial in Santa Monica (NE3107)

      Completed
      • Alzheimer Disease
      • Santa Monica, California
        Neurological Associates - The Interventional Group
      Sep 26, 2022

      Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency, Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy

      Recruiting
      • Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency
      • +51 more
        • Lakewood, California
          Congenital Muscle Disease International Registry (www.cmdir.org)
        Aug 3, 2021

        To Evaluate the Possible Benefit of Astaxanthin on Alzheimer Trial in Kaohsiung (Astaxanthin, Placebo)

        Active, not recruiting
        • To Evaluate the Possible Benefit of Astaxanthin on Alzheimer Disease
        • Astaxanthin
        • Placebo
        • Kaohsiung, Taiwan
          Kaohsiung Medical University Chung-Ho Memorial Hospital
        Aug 15, 2022

        Tau Networks in Psychotic Alzheimer's Disease

        Recruiting
        • Alzheimer Disease
        • +2 more
        • [18F]-PI2620 PET scan
        • Manhasset, New York
          The Feinstein Institutes for Medical Research
        Apr 26, 2023

        Moderate to Severe COPD (COPD) Trial in Worldwide (CHF1535 + CHF5992 dose 1 BID, CHF1535 + CHF5992 dose2 BID, CHF1535 daily

        Completed
        • Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
        • CHF1535 + CHF5992 dose 1 BID
        • +2 more
        • Sofia, Bulgaria
        • +5 more
        Oct 28, 2021

        Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)

        Terminated
        • Alzheimer's Disease
        • Aducanumab (BIIB037)
        • Placebo
        • Phoenix, Arizona
        • +180 more
        Aug 9, 2021

        Transcranial Random Noise, Electroencephalography, Alzheimer Trial in Hefei (High frequency transcranial random noise, Sham high

        Recruiting
        • Transcranial Random Noise
        • +2 more
        • High frequency transcranial random noise
        • Sham high frequency transcranial random noise
        • Hefei, Anhui, China
          Anhui Medical University
        Jun 3, 2023

        Alzheimer Trial (RB-ADSC)

        Not yet recruiting
        • Alzheimer Disease
        • RB-ADSC
        • (no location specified)
        Dec 19, 2022